WealthCollab’s Halozyme HALO Stock Holding History

WealthCollab’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.99K	Hold	51	–	–	﹤0.01%	767
2026 Q1	$3.3K	Hold	51	–	–	﹤0.01%	766
2025 Q4	$3.43K	Hold	51	–	–	﹤0.01%	797
2025 Q3	$3.74K	Hold	51	–	–	﹤0.01%	731
2025 Q2	$2.65K	Buy	+51	New	+$2.9K	﹤0.01%	772

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

WealthCollab's HALO Position: Q2 2026 in Review

WealthCollab held its Halozyme (HALO) position steady in Q2 2026 at 51 shares worth $3.99K. The position accounts for ﹤0.01% of the portfolio, ranked #767.

WealthCollab first reported a position in HALO in Q2 2025 and has held it in 5 quarters since. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

WealthCollab held 51 shares of Halozyme worth $3.99K as of Q2 2026.
WealthCollab left its Halozyme share count unchanged in Q2 2026.
Halozyme made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #767 holding.
WealthCollab first reported a position in Halozyme in Q2 2025 and has held it in 5 quarters since.
672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.